Fiducia

Fiducia focuses on the growth stage, encompassing expansion, late-stage, and restructuring opportunities. The firm also engages in general venture investing, targeting companies that have progressed beyond initial R&D and are ready to scale. Its mandate covers a spectrum from commercialization support to later-stage capital deployment.

The firm concentrates on technology sectors where Japan has traditionally held a research advantage. This includes enterprise software, artificial intelligence and machine learning, industrial technology, and healthcare services. Fiducia's investment thesis is built around commercializing innovation from Japan's engineering, science, and medical institutions.

Fiducia's sourcing model is anchored in Japan's university and corporate research ecosystems. The firm's stated mission is to cultivate Japanese technology and intellectual property at the growth stage, suggesting a proprietary network built around research institutions and deep-tech spinouts. However, the firm has not publicly disclosed specific sourcing partners, university relationships, or a quantitative track record for deal origination.

No. Fiducia is registered as a private equity asset manager under Japan's Kanto Local Finance Bureau (registration number 3242). It is not structured as a single-family office or multi-family office, but rather as an institutional manager deploying capital into growth-stage companies. The origins of its capital base are not publicly disclosed.